EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Milk-Fat-Globule-Membrane-Enriched Dairy Milk Compared with a Soy-Lecithin-Enriched Beverage Did Not Adversely Affect Endotoxemia or Biomarkers of Gut Barrier Function and Cardiometabolic Risk in Adults with Metabolic Syndrome: A Randomized Controlled Crossover Trial

Avinash Pokala, William R Quarles, Joana Ortega-Anaya, Rafael Jimenez-Flores iD, Sisi Cao iD, Min Zeng, Joanna K Hodges iD, Richard S Bruno iD

Nutrients · 23.07.2023 · 15 (14) · 3259

DOI: 10.3390/nu15143259 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 23.07.2023. Verfasst von Avinash Pokala und 7 weiteren Autor:innen. Beteiligte Einrichtung: Human Nutrition Program, The Ohio State University, Columbus, OH 43201, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Endotoxemia, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dairy Management, United States Department of Agriculture, Dairy Management Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Full-fat dairy milk may protect against cardiometabolic disorders, due to the milk fat globule membrane (MFGM), through anti-inflammatory and gut-health-promoting activities. We hypothesized that a MFGM-enriched milk beverage (MEB) would alleviate metabolic endotoxemia in metabolic syndrome (MetS) persons by improving gut barrier function and glucose tolerance. In a randomized crossover trial, MetS persons consumed for two-week period a controlled diet with MEB (2.3 g/d milk phospholipids) or a comparator beverage (COMP) formulated with soy phospholipid and palm/coconut oil. They then provided fasting blood and completed a high-fat/high-carbohydrate test meal challenge for evaluating postprandial metabolism and intestinal permeability. Participants had no adverse effects and achieved high compliance, and there were no between-trial differences in dietary intakes. Compared with COMP, fasting endotoxin, glucose, incretins, and triglyceride were unaffected by MEB. The meal challenge increased postprandial endotoxin, triglyceride, and incretins, but were unaffected by MEB. Insulin sensitivity; fecal calprotectin, myeloperoxidase, and short-chain fatty acids; and small intestinal and colonic permeability were also unaffected by MEB. This short-term study demonstrates that controlled administration of MEB in MetS persons does not affect gut barrier function, glucose tolerance, and other cardiometabolic health biomarkers, which contradicts observational evidence that full-fat milk heightens cardiometabolic risk. Registered at ClinicalTrials.gov (NCT03860584).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeEndotoxemiaCardiovascular DiseasesAdultHumansAnimalsLecithinsIncretinsCross-Over StudiesTriglyceridesMilkPhospholipidsBiomarkersEndotoxinsGlucoseGlycolipidsGlycoproteinsLipid Droplets

Stichwörter der Autor:innen

cardiometabolic healthendotoxinmetabolic syndromemilk fat globule membrane

Substanzen

LecithinsIncretinsTriglyceridesPhospholipidsBiomarkersEndotoxinsGlucosemilk fat globuleGlycolipidsGlycoproteins

Autor:innen und Institutionen

  • Human Nutrition Program, The Ohio State University, Columbus, OH 43201, USA.
  • Department of Food Science and Technology, The Ohio State University, Columbus, OH 43201, USA.
  • Department of Nutritional Sciences, The Pennsylvania State University, State College, PA 16802, USA.

ORCID-Profile: Rafael Jimenez-Flores, Sisi Cao, Joanna K Hodges, Richard S Bruno

Förderung

  • Dairy Management
  • United States Department of Agriculture
  • Dairy Management Inc.
  • Ohio Agricultural Research and Development Center at the Ohio State University

Zitieren

APA

Pokala, A., Quarles, W. R., Ortega-Anaya, J., Jimenez-Flores, R., Cao, S., Zeng, M., Hodges, J. K., & Bruno, R. S. (2023). Milk-Fat-Globule-Membrane-Enriched Dairy Milk Compared with a Soy-Lecithin-Enriched Beverage Did Not Adversely Affect Endotoxemia or Biomarkers of Gut Barrier Function and Cardiometabolic Risk in Adults with Metabolic Syndrome: A Randomized Controlled Crossover Trial. Nutrients, 15(14), 3259. https://doi.org/10.3390/nu15143259

Vancouver

Pokala A, Quarles WR, Ortega-Anaya J, Jimenez-Flores R, Cao S, Zeng M, et al. Milk-Fat-Globule-Membrane-Enriched Dairy Milk Compared with a Soy-Lecithin-Enriched Beverage Did Not Adversely Affect Endotoxemia or Biomarkers of Gut Barrier Function and Cardiometabolic Risk in Adults with Metabolic Syndrome: A Randomized Controlled Crossover Trial. Nutrients. 2023;15(14):3259. doi:10.3390/nu15143259

BibTeX
@article{Pokala2023,
  author = {Pokala, Avinash and Quarles, William R and Ortega-Anaya, Joana and Jimenez-Flores, Rafael and Cao, Sisi and Zeng, Min and Hodges, Joanna K and Bruno, Richard S},
  title = {Milk-Fat-Globule-Membrane-Enriched Dairy Milk Compared with a Soy-Lecithin-Enriched Beverage Did Not Adversely Affect Endotoxemia or Biomarkers of Gut Barrier Function and Cardiometabolic Risk in Adults with Metabolic Syndrome: A Randomized Controlled Crossover Trial},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {14},
  pages = {3259},
  doi = {10.3390/nu15143259}
}
Kostenlos starten →